本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Travere Therapeutics, Inc.

63.48
+0.97001.55%
盤後62.50-0.9800-1.54%18:44 EDT
成交量:222.08萬
成交額:1.41億
市值:59.84億
市盈率:-133.24
高:64.07
開:62.58
低:62.41
收:62.51
52周最高:68.73
52周最低:22.06
股本:9,426.11萬
流通股本:9,276.71萬
量比:1.59
換手率:2.39%
股息:- -
股息率:- -
每股收益(TTM):-0.4764
每股收益(LYR):-0.2864
淨資產收益率:-236.35%
總資產收益率:-3.73%
市淨率:244.01
市盈率(LYR):-221.69

資料載入中...

2022/03/09

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/03/09

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/02/24

重要事件披露

8-K - Current report
2022/02/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/10

重要事件披露

8-K - Current report
2022/01/06

重要事件披露

8-K - Current report
2021/12/22

重要事件披露

8-K - Current report
2021/12/15

重要事件披露

8-K - Current report
2021/10/29

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/28

重要事件披露

8-K - Current report
2021/10/12

重要事件披露

8-K - Current report
2021/09/17

重要事件披露

8-K - Current report
2021/09/15

重要事件披露

8-K - Current report